---
title: "Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461) in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer"
date: "2025-09-08T04:00:00.000Z"
publishedDate: "8 septembre 2025"
summary: "Conditions : Metastatic Colorectal Adenocarcinoma; Refractory Colorectal Adenocarcinoma; Stage III Colorectal Cancer AJCC v8; Stage IV Colorectal Cancer AJCC v8; Unresectable Colorectal Adenocarcinoma Interventions : Procedure: Biopsy Procedure; Procedure: Biospecimen Collection; Biological: Cemiplimab; Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging; Drug: Pidnarulex; Procedure: Positron Emission Tomography Sponsors : National Cancer Institute (NCI) Not yet recruiting"
importance: ""
sourceUrl: "https://clinicaltrials.gov/study/NCT07147231?term=interventional+radiology&aggFilters=status%3A"
tags: ["France", "Actualité", "ClinicalTrials.gov — ta recherche"]
permalink: "/papers/2025-09-08-testing-the-effectiveness-of-the-anti-cancer-drug-pidnarulex-cx-5461-in-combination-with-another-anti-cancer-drug-cemiplimab-regn2810-in-treating-refractory-microsatellite-stable-colorectal-cancer"
imageUrl: ""
imageCredit: ""
---

## L’essentiel

Conditions : Metastatic Colorectal Adenocarcinoma; Refractory Colorectal Adenocarcinoma; Stage III Colorectal Cancer AJCC v8; Stage IV Colorectal Cancer AJCC v8; Unresectable Colorectal Adenocarcinoma Interventions : Procedure: Biopsy Procedure; Procedure: Biospecimen Collection; Biological: Cemiplimab; Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging; Drug: Pidnarulex; Procedure: Positron Emission Tomography Sponsors : National Cancer Institute (NCI) Not yet recruiting

## Lien source

https://clinicaltrials.gov/study/NCT07147231?term=interventional+radiology&aggFilters=status%3A
